An Investigation to Validate Speech Perception Assessment for Adult Cochlear Recipients Using a Mobile Research App

NCT ID: NCT06098482

Last Updated: 2025-04-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-05

Study Completion Date

2027-05-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is a feasibility, prospective, repeated-measures, multi-country, multi-centre, study of the Mobile Research App to measure and validate speech perception endpoints in adult cochlear implant recipients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hearing Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Delivery of speech perception materials in-clinic using the Mobile Research App (MRA)

Cochlear implant recipients will participate in this arm (sub-investigation AI5841A).

Group Type EXPERIMENTAL

Mobile Research App (MRA)

Intervention Type DEVICE

The MRA (research tool) is a platform used for the delivery of speech perception material in-clinic outside the sound booth or in the home of the hearing-impaired recipients. The MRA speech testing module delivers speech material via streaming to the single implanted ears of cochlear implant recipients. The recipient listens to the speech material and responds with what was heard via the app. Speech is streamed via Bluetooth from the iOS device to the sound processor of the CI-recipient.

SOC/validated delivery of the speech perception test material

Intervention Type OTHER

This involves the delivery of speech perception test material in the sound booth in a clinic.

Delivery of speech perception materials in-clinic and at home using the Mobile Research App (MRA)

Cochlear implant and hearing aid recipients will participate in this arm (sub-investigation AI5841B).

Group Type EXPERIMENTAL

Mobile Research App (MRA)

Intervention Type DEVICE

The MRA (research tool) is a platform used for the delivery of speech perception material in-clinic outside the sound booth or in the home of the hearing-impaired recipients. The MRA speech testing module delivers speech material via streaming to the single implanted ears of cochlear implant recipients. The recipient listens to the speech material and responds with what was heard via the app. Speech is streamed via Bluetooth from the iOS device to the sound processor of the CI-recipient.

SOC/validated delivery of the speech perception test material

Intervention Type OTHER

This involves the delivery of speech perception test material in the sound booth in a clinic.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mobile Research App (MRA)

The MRA (research tool) is a platform used for the delivery of speech perception material in-clinic outside the sound booth or in the home of the hearing-impaired recipients. The MRA speech testing module delivers speech material via streaming to the single implanted ears of cochlear implant recipients. The recipient listens to the speech material and responds with what was heard via the app. Speech is streamed via Bluetooth from the iOS device to the sound processor of the CI-recipient.

Intervention Type DEVICE

SOC/validated delivery of the speech perception test material

This involves the delivery of speech perception test material in the sound booth in a clinic.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults 18 years of age or older.
* Uses a hearing device or devices (hearing aid/s and/or cochlear implant/s).
* Fluent speaker in the language used to assess clinical performance as judged by the investigator.
* Willing and able to provide written informed consent.

Exclusion Criteria

* Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator.
* Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling.
* Cochlear employees or employees of Contract Research Organisations or contractors engaged by Cochlear for the purposes of this investigation.
* Currently participating, or participated within the last 30 days, in another interventional clinical investigation/trial involving an investigational drug or device (unless the other investigation was/is a Cochlear sponsored investigation and determined by the investigator or Sponsor to not impact this investigation).
* Women who are pregnant.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cochlear

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Denver Research and Technology Labs

Lone Tree, Colorado, United States

Site Status COMPLETED

HEARnet Clinical Studies

Melbourne, Victoria, Australia

Site Status ACTIVE_NOT_RECRUITING

European Institute for Otorhinolaryngology (EIORL) ENT department Sint-Augustinus Antwerp

Antwerp, Antwerp, Belgium

Site Status RECRUITING

Hoorzorg van Looveren

Wommelgem, Antwerp, Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Geert De Ceulaer

Role: CONTACT

+32486893006

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Andrzej Zarowski, MD, PhD

Role: primary

34433604 ext. +32

Nancy Van Looveren, Aud

Role: primary

33227391 ext. +32

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AI5841

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.